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Congenital erythropoietic porphyria (CEP) (Gunther's Disease)
is autosomal recessive in inheritance and also the only type of porphyria that is completely erythropoietic in origin1. It is characterized by the massive over production ofporphyrins so that the patient usually presents at birth or within the first few years of life. Its association with congenital adrenal hyperplasia (CAH) does not appear to have been previously reported.
Case report This 7-year-old adopted boy was diagnosed as having CAH (21-hydroxylase deficiency) shortly after birth and is now well controlled on daily hydrocortisone and fludrocortisone. Since the age of 3 he suffered with intermittent blistering mainly involving the upper limbs and face to which there appears to be no regular pattern or obvious relation to sun exposure. His adopting parents had also noted a pink tinge to his teeth and the rich orange colour of his urine. The genetic parents were of different nationalities and not known to be related.
On examination his height was on the 3rd centile and his weight on the 75th. There was marked facial hypertrichosis and varioliform scars on the dorsa of the hands and on the face. Erythrodontia was present which is thought to result from the affinity of calcium phosphate for porphyrinsi. Both the teeth and urine fluoresced under Wood's light.
Routine haematological and biochemical investigations were within normal limits. In particular there was no evidence of any significant haemolysis.
Porphyrin results are given in Table 1 . Urinary porphobilinogen and 5-aminolaevulinic acid levels were normal. The urine, however, did contain excessive amounts of mesofuscinoid pigment which has been noted in CEP3. Thin layer chromatography (TLC) of urinary coproporphyrins revealed almost equal amounts of the I and III isomers. Faecal residue showed no excess of the 'X-porphyrin' that is excreted in variegate porphyria.
Endocine investigations including serum concentrations of cortisol, 17-hydroxyprogesterone, testosterone, androstenedione and dehydroepiandrosterone were within normal limits and compatible with controlled CAH.
Profile analysis of urinary steroids using capillary column gas chromatography showed high excretion of 5i reduced metabolites of exogenous hydrocortisone (tetrahydrocortisol) relative to 5a in a ratio of 14:1 (normal males 3:2, and controlled CAH 1:1).
The patient is now receiving 100 mg P-Bcarotene daily and has noticed no further blistering.
Discussion
Production of the normal type m isomer of uroporphyrinogen (UP) from porphobilinogen (PBG) depends on the concerted action of 2 enzymes, hydroxymethylbilane (HMB) synthase (also called UP I synthase or PGB deaminase) and UP m synthase (see Figure 1 ). HMB synthase converts PBG to an open chain tetrapyrrole intermediate, HMB, which in the absence of UP m synthase undergoes spontaneous cyclization to UP I and subsequently by slow decarboxylation to coproporphyrinogen I. These I type isomers are not substrates for the next enzyme in haem synthesis and therefore accumulate producing the clinical symptoms.
Most evidence points to the lack of UP m synthase as the primary enzyme abnormality. In normal erythrocytes it is found in excess relative to HMB synthase, favouring the production of UP III but its activity has been shown to be deficient in the erythrocytes of patients with CEP 7 and to a lesser extent in their skin fibroblasts7' and erythrocytes of isymptomatic carriersPs. However, since these patients also frequently excrete excess amounts of the normal type m isomers10'11 as seen in this patient and especially in those with haemolytic complications, it suggests that it is not simply a lack of UP mI synthase but perhaps an abnormality in its activity relative to HMEB synthase since the two enzymes may be associated as an enzyme complex2.
These patients frequently have a variable and periodic haemolytic anaemiall and ineffective erythropoiesis. The reasons for these findings are unknown. Suggested mechanisms include increased osmotic fragility secondary to the excess uroporphyrins within the red cells12, an intrinsic erythrocyte abnormalityl3'14 or intravascular photohaemolysis within dermal capillaries. These haematological abnormalities are important since the resultant marrow hyperplasia stimulates further haem synthesis and thus accumulation of porphyrins. Attempts have therefore been made to reduce porphyrin production by reducing red cell Figure 1 . Production of uroporphyrinogen from porphobilinogen synthesis and destruction. Splenectomy has been reported to improve both the anaemia and the photosensitivity in some cases'11-3 but not in others2,14. Intravenous haematin'5 and transfusions with the induction of polycythaemia'6 can also reduce porphyrin formation in CEP. Unfortunately none of these methods has been generally successful and are potentially hazardous.
A possible association between acute intermittent porphyria and a deficiency of hepatic Wl-5a reductase has been shown17. Thus some endogenous and exogenous hormones and precursors of appropriate structure are metabolized preferentially via the 5,B pathway. The 5j# metabolites like many drugs induce 6-aminolaevulinic acid synthase activity leading to disease exacerbation. In our patient the CAH is well controlled with no evidence for any significant increase in cortisol precursors. Although there is some evidence suggesting that cortisol at high levels may be metabolized preferentially via the 5 jB pathway (Dr J Honour, personal communication), in this case the high ratio of5# to 5a metabolites ofhydrocortisone suggests that there may be a deficiency of hepatic A4-5a reductase. Whatever the mechanism for their production these 5 3 metabolites could explain the high levels of type IH porphyrin excretion since there was no evidence to support a significant haemolytic state.
CAH with 21-hydroxylase deficiency is a relatively common condition but its association with CEP, as well as the anomalous steroid reduction seen in our patient, do not appear to have been described before. between extensive lesions and the presence of a twin or triplet fetus papyraceous has previously been reported2', but they have not been described in cases of congenital toxoplasmosis. We present an infant with extensive skin defects and congenital toxoplasmosis who was the sole survivor of a twin pregnancy.
Congenital skin defects, twins and toxoplasmosis
Case report A male baby weighing 2030 g was born at term to a 23-yearold gravida 2, para 2, healthy mother. Extensive, partially healed skin leions, were apparent at delivery (igures 1 and 2). An ultrasonographic scan at 18 weeks gestation had shown a twin pregnancy, however twin 2 was only 12.5 weeks size and no fetal heart beat was detected. Serial scans of the surviving twin demonstrated intrauterine growth retardation but the pregnancy continued to term. After spontaneous onset oflabour, delivery was normal,-apart from 0141-0768/89/ 020108-02/402.00/0 ©1989 The Royal Society of Medicine
